Log in to save to my catalogue

An evaluation of the cost of human papilloma virus (HPV) vaccine delivery in Zambia

An evaluation of the cost of human papilloma virus (HPV) vaccine delivery in Zambia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2114652790cf41eea8f29e32a7fa6372

An evaluation of the cost of human papilloma virus (HPV) vaccine delivery in Zambia

About this item

Full title

An evaluation of the cost of human papilloma virus (HPV) vaccine delivery in Zambia

Publisher

England: BioMed Central Ltd

Journal title

BMC infectious diseases, 2024-04, Vol.24 (1), p.369-369, Article 369

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Human papillomavirus (HPV) is a common sexually transmitted infection and the leading cause of cervical cancer. The HPV vaccine is a safe and effective way to prevent HPV infection. In Zambia, the vaccine is given during Child Health Week to girls aged 14 years who are in and out of school in two doses over two years. The focus of this evaluation w...

Alternative Titles

Full title

An evaluation of the cost of human papilloma virus (HPV) vaccine delivery in Zambia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2114652790cf41eea8f29e32a7fa6372

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2114652790cf41eea8f29e32a7fa6372

Other Identifiers

ISSN

1471-2334

E-ISSN

1471-2334

DOI

10.1186/s12879-024-09222-2

How to access this item